Cantor Fitzgerald analyst Joseph France reiterated a Buy rating on Healthcare Realty (NYSE: HR) yesterday and set a price target of $38. The company’s shares closed yesterday at $27.70, close to its 52-week low of $27.48.

France observed:

“HR reported in-line 4Q17 results and expects more capital recycling in 2018. The company also started a major development in Seattle. 4Q17 revenue was $107.7 million vs. our $111.4 million estimate, and 4Q17 normalized FFO was $0.38 vs. our $0.39 estimate.”

According to TipRanks.com, France is a 4-star analyst with an average return of 7.3% and a 50.7% success rate. France covers the Services sector, focusing on stocks such as Cross Country Healthcare, Five Star Quality Care, and WellCare Health Plans.

Healthcare Realty has an analyst consensus of Moderate Buy, with a price target consensus of $34.33.

Healthcare Realty’s market cap is currently $3.46B and has a P/E ratio of 28.55. The company has a book value ratio of 1.8557.

Based on the recent corporate insider activity of 38 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Healthcare Realty Trust, Inc. is a self-managed and self-administered real estate investment trust which engages in the acquisition, lease, finance, management, development, and redevelopment of income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. The company was founded by David R. Emery in 1992 and is headquartered in Nashville, TN.